Italy suspends use of AstraZeneca COVID vaccine nationwide
ROME (Reuters) - Italy on Monday suspended the use of the AstraZeneca COVID-19 vaccine, making it the latest European country to put the product on hold following reports of recipients falling ill.
The announcement came shortly after Germany took the same step, and followed the seizure of hundreds of thousands of doses of the vaccine by Italian prosecutors in the northern region of Piedmont.
The Italian medicines authority AIFA said it was taking the decision as a "precautionary and temporary measure" pending rulings by the European Medicines Agency.
(Reporting by Angelo Amante, writing by Gavin Jones, editing by Crispian Balmer)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AstraZeneca's camizestrant fails primary endpoint in breast cancer trial
- Russian nuclear head says Ukraine attacked fuel trucks, endangered Zaporizhzhia plant
- Equity risk premium falls to 2002 levels. What it means for stocks
Create E-mail Alert Related Categories
General News, ReutersSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share